Publications

Public health genomics

A Value-Based Evaluation Framework for Guiding the Adoption and Scale-Up of Cancer Genomics Interventions.

02-03-2026

International journal of computer assisted radiology and surgery

Machine learning-based treatment outcome prediction in head and neck cancer using integrated noninvasive diagnostics.

01-03-2026

The Lancet. Oncology

Percutaneous hepatic perfusion combined with ipilimumab and nivolumab for metastatic uveal melanoma (CHOPIN): a single-centre, open-label, randomised, phase 2 trial.

01-03-2026

Nature cancer

Setting higher standards for reports of microbial species in human cancers.

01-03-2026

The Lancet. Oncology

MRI-based personalisation of neoadjuvant chemotherapy duration in HER2-positive early breast cancer (TRAIN-3): primary results from a multicentre, single-arm, phase 2 study.

01-03-2026

Abdominal radiology (New York)

Advancing MRI diagnostic practices in rectal cancer: exploring the impact of web-based multi-reader study participation.

01-03-2026

Nature medicine

Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis from the phase 2 PRADO-trial.

01-03-2026

Annals of surgical oncology

Rationales for Prehabilitation Programs in Patients Preparing for Oncologic Surgery: A Systematic Review.

01-03-2026

Psycho-oncology

Death Anxiety During the Last Year of Life in Patients With Advanced Cancer: Longitudinal Results From the eQuiPe Study.

01-03-2026

Nature

Regulatory grammar in human promoters uncovered by MPRA-based deep learning.

01-03-2026

Trends in genetics : TIG

Gene expression noise in development: genome-wide dynamics.

01-03-2026

Molecular diagnosis & therapy

Interlesional Heterogeneity of EGFR Mutations: A Systematic Review and Meta-analysis.

01-03-2026

Molecular & cellular proteomics : MCP

Cell-State-Specific Drug Responses are Associated With Differences in Signaling Network Wiring.

01-03-2026

International journal of clinical oncology

Pan-Asian subgroup analysis of EV-302/KEYNOTE-A39: a phase 3 study to evaluate enfortumab vedotin and pembrolizumab in patients with untreated advanced urothelial carcinoma.

01-03-2026

Nature medicine

Clinical development of cancer vaccines.

01-03-2026

Nature reviews. Clinical oncology

From detection to direction: ctDNA-guided personalized therapy for muscle-invasive bladder cancer.

01-03-2026

Clinical pharmacology and therapeutics

Reducing the Burden of Interaction Studies in Cancer Patients Using a Stable Isotopically Labeled Microtracer: A Proof-of-Concept Study with Alectinib.

01-03-2026

CPT: pharmacometrics & systems pharmacology

Semi-Physiological Population Pharmacokinetic Modeling of Oral and Intravenous Paracetamol to Quantify Presystemic Metabolism and Enterohepatic Recirculation.

01-03-2026

Health psychology review

Maintenance of lifestyle changes following lifestyle interventions in breast cancer survivors: a systematic literature review.

01-03-2026

The Lancet. Oncology

The OligoPanc project: an interdisciplinary expert consensus statement on oligometastatic pancreatic cancer.

01-03-2026

European journal of radiology

Corrigendum to "RECIST progression: Patterns among target, non-target, non-measurable and new lesions progression" [Eur. J. Radiol. 186 (2025) 112038].

01-03-2026

Annals of oncology : official journal of the European Society for Medical Oncology

Repertoire and clinical hierarchy of AR locus alterations in castration-resistant prostate cancer.

01-03-2026

Annals of surgical oncology

International Survey on Evidence for Index Lymph Node Surgery After Neoadjuvant Systemic Therapy for Stage III Melanoma.

01-03-2026

Journal of biomedical optics

Perspective on the current state of hyperspectral/multispectral imaging for minimally invasive surgery.

01-03-2026

Clinical breast cancer

Long-Term Health Issues of Adolescent and Young Adult Breast Cancer Survivors.

01-03-2026

Annals of surgical oncology

ASO Author Reflections: Reported rationales for the content of prehabilitation programs in the oncology setting.

01-03-2026

European journal of nuclear medicine and molecular imaging

[¹⁸F]FDG-PET/CT's change in total lesion glycolysis can accurately identify early response upon neoadjuvant immunotherapy prior to curative-intent surgery in cutaneous squamous cell carcinoma; MATISSE trial.

01-03-2026

Annals of surgical oncology

ASO Visual Abstract: Prognostic Value of Circulating Tumor DNA for Recurrence and Survival in Patients Undergoing Local Treatment for Initially Unresectable RAS/RAF Mutated Colorectal Cancer Liver Metastases.

01-03-2026

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Are the CTV-to-PTV margins currently used in online adaptive radiotherapy for prostate cancer too large? The impact of the distribution of microscopic disease on treatment margin requirements.

01-03-2026

Nature cancer

Temporal and spatial composition of the tumor microenvironment predicts response to immune checkpoint inhibition in metastatic TNBC.

01-03-2026

Scientific reports

Effect of curcumin on the gut microbiota of patients with ulcerative colitis, Crohn's disease and healthy participants.

01-03-2026

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Acute adverse events in the DESTINATION 1 trial: A prospective prostate SBRT dose de-escalation feasibility study.

01-03-2026

Technical innovations & patient support in radiation oncology

Direct-to-treatment MRI-guided prostate radiotherapy using a generic patient-agnostic reference plan.

01-03-2026

Nature chemistry

Monovalent pseudo-natural products supercharge degradation of IDO1 by its native E3 KLHDC3.

01-03-2026

ESMO open

Nivolumab plus gemcitabine-cisplatin for unresectable or metastatic urothelial carcinoma: health-related quality-of-life analyses from the phase III CheckMate 901 trial.

01-03-2026

NAR genomics and bioinformatics

DEprot: a comprehensive R-package for the analysis of label-free quantitation mass spectrometry data.

01-03-2026

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Prevalence of concurrent severe self-reported late symptoms and functional limitations in cancer survivors: a cross-sectional study of sociodemographic, clinical, and lifestyle associations.

28-02-2026

Frontiers in toxicology

Evaluating chemotherapy-driven placental alterations and their impact on fetal development.

27-02-2026

Transplantation and cellular therapy

Advancing Cell Therapies for Solid Tumors: A Pathway to Overcome Biological, Operational, and Regulatory Hurdles.

26-02-2026

Breast cancer research : BCR

Pathway activity profiling can predict neoadjuvant endocrine therapy response in HR+ HER2- postmenopausal early stage breast cancer.

25-02-2026

European journal of cancer (Oxford, England : 1990)

Assessing quality of life in individuals with hereditary cancer risk: Results from phases 1-3a of the EORTC QLQ-HCR30 questionnaire.

25-02-2026

Blood advances

Fludarabine dosing in the youngest children: safety first.

24-02-2026

Communications biology

PRC2 loss impairs small cell lung cancer tumorigenesis and enhances sensitivity to G9a/GLP inhibition.

21-02-2026

iScience

Compartment-specific tumor-infiltrating immune cells and prognosis in breast cancer.

20-02-2026

Health and quality of life outcomes

Incorporating patients' input in the development and validation of patient-reported outcome measures in oncology: a comprehensive scoping review.

18-02-2026

Cell reports. Medicine

Liver metastases dampen IL18-driven γδ T cell activity and immunotherapy responsiveness in colorectal cancer.

17-02-2026

Cellular oncology (Dordrecht, Netherlands)

Disconnect between in vitro and in vivo efficacy of the MPS1 inhibitor NTRC 0066-0 against glioblastoma.

16-02-2026

International journal of cancer

Experiences of metastatic prostate cancer patients with a mainstream genetic testing pathway.

15-02-2026

International journal of cancer

Cause-specific mortality after a diagnosis of ductal carcinoma in situ: Associations with screening and socio-economic status.

15-02-2026

Therapeutic drug monitoring

Impact of Abiraterone Therapeutic Drug Monitoring on Cortisol as a Surrogate Biomarker of CYP17 Inhibition in Metastatic Prostate Cancer Treatment.

13-02-2026

A Value-Based Evaluation Framework for Guiding the Adoption and Scale-Up of Cancer Genomics Interventions.

Machine learning-based treatment outcome prediction in head and neck cancer using integrated noninvasive diagnostics.

Percutaneous hepatic perfusion combined with ipilimumab and nivolumab for metastatic uveal melanoma (CHOPIN): a single-centre, open-label, randomised, phase 2 trial.

Setting higher standards for reports of microbial species in human cancers.

MRI-based personalisation of neoadjuvant chemotherapy duration in HER2-positive early breast cancer (TRAIN-3): primary results from a multicentre, single-arm, phase 2 study.

Advancing MRI diagnostic practices in rectal cancer: exploring the impact of web-based multi-reader study participation.

Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis from the phase 2 PRADO-trial.

Rationales for Prehabilitation Programs in Patients Preparing for Oncologic Surgery: A Systematic Review.

Death Anxiety During the Last Year of Life in Patients With Advanced Cancer: Longitudinal Results From the eQuiPe Study.

Regulatory grammar in human promoters uncovered by MPRA-based deep learning.

Gene expression noise in development: genome-wide dynamics.

Interlesional Heterogeneity of EGFR Mutations: A Systematic Review and Meta-analysis.

Cell-State-Specific Drug Responses are Associated With Differences in Signaling Network Wiring.

Pan-Asian subgroup analysis of EV-302/KEYNOTE-A39: a phase 3 study to evaluate enfortumab vedotin and pembrolizumab in patients with untreated advanced urothelial carcinoma.

Clinical development of cancer vaccines.

From detection to direction: ctDNA-guided personalized therapy for muscle-invasive bladder cancer.

Reducing the Burden of Interaction Studies in Cancer Patients Using a Stable Isotopically Labeled Microtracer: A Proof-of-Concept Study with Alectinib.

Semi-Physiological Population Pharmacokinetic Modeling of Oral and Intravenous Paracetamol to Quantify Presystemic Metabolism and Enterohepatic Recirculation.

Maintenance of lifestyle changes following lifestyle interventions in breast cancer survivors: a systematic literature review.

The OligoPanc project: an interdisciplinary expert consensus statement on oligometastatic pancreatic cancer.

Corrigendum to "RECIST progression: Patterns among target, non-target, non-measurable and new lesions progression" [Eur. J. Radiol. 186 (2025) 112038].

Repertoire and clinical hierarchy of AR locus alterations in castration-resistant prostate cancer.

International Survey on Evidence for Index Lymph Node Surgery After Neoadjuvant Systemic Therapy for Stage III Melanoma.

Perspective on the current state of hyperspectral/multispectral imaging for minimally invasive surgery.

Long-Term Health Issues of Adolescent and Young Adult Breast Cancer Survivors.

ASO Author Reflections: Reported rationales for the content of prehabilitation programs in the oncology setting.

[18F]FDG-PET/CT's change in total lesion glycolysis can accurately identify early response upon neoadjuvant immunotherapy prior to curative-intent surgery in cutaneous squamous cell carcinoma; MATISSE trial.

ASO Visual Abstract: Prognostic Value of Circulating Tumor DNA for Recurrence and Survival in Patients Undergoing Local Treatment for Initially Unresectable RAS/RAF Mutated Colorectal Cancer Liver Metastases.

Are the CTV-to-PTV margins currently used in online adaptive radiotherapy for prostate cancer too large? The impact of the distribution of microscopic disease on treatment margin requirements.

Temporal and spatial composition of the tumor microenvironment predicts response to immune checkpoint inhibition in metastatic TNBC.

Effect of curcumin on the gut microbiota of patients with ulcerative colitis, Crohn's disease and healthy participants.

Acute adverse events in the DESTINATION 1 trial: A prospective prostate SBRT dose de-escalation feasibility study.

Direct-to-treatment MRI-guided prostate radiotherapy using a generic patient-agnostic reference plan.

Monovalent pseudo-natural products supercharge degradation of IDO1 by its native E3 KLHDC3.

Nivolumab plus gemcitabine-cisplatin for unresectable or metastatic urothelial carcinoma: health-related quality-of-life analyses from the phase III CheckMate 901 trial.

DEprot: a comprehensive R-package for the analysis of label-free quantitation mass spectrometry data.

Prevalence of concurrent severe self-reported late symptoms and functional limitations in cancer survivors: a cross-sectional study of sociodemographic, clinical, and lifestyle associations.

Evaluating chemotherapy-driven placental alterations and their impact on fetal development.

Advancing Cell Therapies for Solid Tumors: A Pathway to Overcome Biological, Operational, and Regulatory Hurdles.

Pathway activity profiling can predict neoadjuvant endocrine therapy response in HR+ HER2- postmenopausal early stage breast cancer.

Assessing quality of life in individuals with hereditary cancer risk: Results from phases 1-3a of the EORTC QLQ-HCR30 questionnaire.

Fludarabine dosing in the youngest children: safety first.

PRC2 loss impairs small cell lung cancer tumorigenesis and enhances sensitivity to G9a/GLP inhibition.

Compartment-specific tumor-infiltrating immune cells and prognosis in breast cancer.

Incorporating patients' input in the development and validation of patient-reported outcome measures in oncology: a comprehensive scoping review.

Liver metastases dampen IL18-driven γδ T cell activity and immunotherapy responsiveness in colorectal cancer.

Disconnect between in vitro and in vivo efficacy of the MPS1 inhibitor NTRC 0066-0 against glioblastoma.

Experiences of metastatic prostate cancer patients with a mainstream genetic testing pathway.

Cause-specific mortality after a diagnosis of ductal carcinoma in situ: Associations with screening and socio-economic status.

Impact of Abiraterone Therapeutic Drug Monitoring on Cortisol as a Surrogate Biomarker of CYP17 Inhibition in Metastatic Prostate Cancer Treatment.

This site uses cookies

[¹⁸F]FDG-PET/CT's change in total lesion glycolysis can accurately identify early response upon neoadjuvant immunotherapy prior to curative-intent surgery in cutaneous squamous cell carcinoma; MATISSE trial.